Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDeferred TaxesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Net Equity Issued and Repurchased (2020 - 2025)

Historic Net Equity Issued and Repurchased for Sanofi (SNY) over the last 3 years, with Q3 2025 value amounting to $10.4 billion.

  • Sanofi's Net Equity Issued and Repurchased changed N/A to $10.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $10.4 billion, marking a year-over-year change of. This contributed to the annual value of $8.7 billion for FY2025, which is 744.4% up from last year.
  • Latest data reveals that Sanofi reported Net Equity Issued and Repurchased of $10.4 billion as of Q3 2025.
  • In the past 5 years, Sanofi's Net Equity Issued and Repurchased ranged from a high of $10.4 billion in Q3 2025 and a low of $11.8 million during Q4 2021